Table 1 Factors associated with progression 1 or more stages between two paired liver biopsies in 135 patients from Spain in the multivariate study
Parameter | Categories | RR (95% CI) | p |
|---|---|---|---|
Undetectable HIV viremia1 | Yes vs. No | 0.61 (0.39-0.93) | 0.03 |
Baseline necroinflammatory activity | L2-3 vs. L0-1 | 1.77 (1.16-2.7) | 0.009 |
Time between liver biopsies | Per 1 year increase | 1.11 (1.03-1.2) | 0.01 |
Response to anti-HCV treatment | ETR vs. no ETR | 0.41 (0.19-0.88) | 0.02 |